Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.705
+0.145 (4.07%)
At close: Aug 17, 2026, 4:00 PM EDT
3.770
+0.065 (1.75%)
After-hours: Aug 17, 2026, 7:55 PM EDT
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 106 employees as of December 31, 2025. The number of employees decreased by 60 or -36.14% compared to the previous year.
Employees
106
Change (1Y)
-60
Growth (1Y)
-36.14%
Revenue / Employee
n/a
Profits / Employee
-$1,316,462
Market Cap
265.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | -60 | -36.14% |
| Dec 31, 2024 | 166 | -2 | -1.19% |
| Dec 31, 2023 | 168 | 12 | 7.69% |
| Dec 31, 2022 | 156 | -21 | -11.86% |
| Dec 31, 2021 | 177 | 53 | 42.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| ProQR Therapeutics | 187 |
| Entrada Therapeutics | 152 |
| Adagene | 128 |
| AC Immune | 122 |
| Orchestra BioMed Holdings | 86 |
| Lineage Cell Therapeutics | 77 |
| Cartesian Therapeutics | 75 |
ZNTL News
- 5 hours ago - Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 1 day ago - Zentalis announecs common stock offering, no amount given - TheFly
- 3 days ago - Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering - GlobeNewsWire
- 4 days ago - Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 10 days ago - Zentalis price target raised to $5 from $4 at Morgan Stanley - TheFly
- 11 days ago - Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 11 days ago - Zentalis Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 11 days ago - Zentalis Pharmaceuticals Earnings release: Q2 2026 - Filings